Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • verb

Words related to hypertrophy

undergo hypertrophy

Related Words

References in periodicals archive ?
The chemical, PDE5i, effectively prevented the heart increasing in size and changing shape in patients with left ventricular hypertrophy.
Heart hypertrophy can be hereditary, can be caused by diseases such as diabetes, or can be caused by doing too much strenuous exercise.
Scientists at Abertay University, Dundee, use chemicals to simulate hypertrophy, allowing new drugs to be tested.
The aortic valve disease was the main reason for his left ventricular hypertrophy, manifested in the electrocardiogram by [RV.
Although lipomatous hypertrophy of interatrial septum has been known since 1960's, its pathophysiology is still unclear.
Cardiac hypertrophy is a slow thickening of the heart muscle that shrinks the interior volume of the heart, forcing the organ to work harder to pump a diminishing volume of blood.
In these cases otherwise insignificant basal septal hypertrophy may cause LVOT obstruction with the usual dobutamine dosage (3).
Left Ventricular Hypertrophy (LVH) in ESRD patients on hemodialysis is associated with increased cardiovascular morbidity and mortality.
During her internship, Abdelaziz developed new basic science skills including isolating neonatal rat ventricular cardiomyocytes and characterising them for cardiac hypertrophy.
In these cases, various criteria can help to differentiate physiological from pathological LV hypertrophy, and LV wall thickness reduction with deconditioning (detraining) is accepted as a distinctive marker of AH.
HOUSTON--Physical fitness nearly halved the risk of death in men with type 2 diabetes, regardless of whether they had left ventricular hypertrophy, a longitudinal study of 866 patients found.
Therefore, in this study, we aimed to demonstrate the possible hypertrophy of the finger flexor tendons of archers by using sonography.
Idiopathic muscular hypertrophy of the gastrointestinal tract is a very rare condition of unknown aetiology with no predisposing factors.
Several miRNAs are differentially produced in cardiac hypertrophic tissue, compared with normal tissue, and may contribute to the development of cardiomyocyte hypertrophy (2, 3).
Reasoning that the lack of effect might be the result of inadequate dosing in previous trials, researchers designed a trial that tested double, then triple, the standard dose against an identical-looking placebo in 369 men with lower urinary tract symptoms typical of benign prostatic hypertrophy.